Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.
about
APP binds DR6 to trigger axon pruning and neuron death via distinct caspasesThe death domain-containing protein Unc5CL is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascadeDeath receptor 6 negatively regulates oligodendrocyte survival, maturation and myelinationStructure of the extracellular domains of human and Xenopus Fn14: implications in the evolution of TWEAK and Fn14 interactionsTWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regenerationNon-Canonical NF-κB Signaling Initiated by BAFF Influences B Cell Biology at Multiple JuncturesAssembly and structural properties of glucocorticoid-induced TNF receptor ligand: Implications for functionStructural basis for ligand-mediated mouse GITR activationEvolution of GITRL immune function: Murine GITRL exhibits unique structural and biochemical properties within the TNF superfamily1.8 Å structure of murine GITR ligand dimer expressed inDrosophila melanogasterS2 cellsOn death receptor 3 and its ligands…Galectin-9 controls the therapeutic activity of 4-1BB-targeting antibodiesAnti-tumour effects of a specific anti-ADAM17 antibody in an ovarian cancer model in vivoTWEAK Regulates Muscle Functions in a Mouse Model of RNA Toxicity.The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasisTNF superfamily: a growing saga of kidney injury modulators.Endothelial TNF receptor 2 induces IRF1 transcription factor-dependent interferon-β autocrine signaling to promote monocyte recruitment.CD32a antibodies induce thrombocytopenia and type II hypersensitivity reactions in FCGR2A mice.The Pseudokinase MLKL and the Kinase RIPK3 Have Distinct Roles in Autoimmune Disease Caused by Loss of Death-Receptor-Induced Apoptosis.Identification of the Schistosoma mansoni TNF-alpha receptor gene and the effect of human TNF-alpha on the parasite gene expression profile.Cellular IAPs inhibit a cryptic CD95-induced cell death by limiting RIP1 kinase recruitmentActivation of myeloid and endothelial cells by CD40L gene therapy supports T-cell expansion and migration into the tumor microenvironmentExtensive phenotypic characterization of a new transgenic mouse reveals pleiotropic perturbations in physiology due to mesenchymal hGH minigene expression.Two distinct mechanisms underlie progesterone-induced proliferation in the mammary gland.Age-dependent maintenance of motor control and corticostriatal innervation by death receptor 3.Murine B cell development and antibody responses to model antigens are not impaired in the absence of the TNF receptor GITR.The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.SEF/IL-17R (SEFIR) is not enough: an extended SEFIR domain is required for il-17RA-mediated signal transduction.Sequence, structure, function, immunity: structural genomics of costimulation.Activation of the pseudokinase MLKL unleashes the four-helix bundle domain to induce membrane localization and necroptotic cell death.The TNF-family cytokine TL1A inhibits proliferation of human activated B cellsNo evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unitTWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domainResistance to oncolytic myxoma virus therapy in nf1(-/-)/trp53(-/-) syngeneic mouse glioma models is independent of anti-viral type-I interferon.Development of human serine protease-based therapeutics targeting Fn14 and identification of Fn14 as a new target overexpressed in TNBC.In TNF-stimulated cells, RIPK1 promotes cell survival by stabilizing TRAF2 and cIAP1, which limits induction of non-canonical NF-kappaB and activation of caspase-8Generation of hematopoietic humanized mice in the newborn BALB/c-Rag2null Il2rγnull mouse model: a multivariable optimization approachInfluence of the implantation site on the sensitivity of patient pancreatic tumor xenografts to Apo2L/TRAIL therapy.Progranulin-derived Atsttrin directly binds to TNFRSF25 (DR3) and inhibits TNF-like ligand 1A (TL1A) activity.
P2860
Q22251088-47ED8A67-69B1-48AD-9C80-F88E3C4F0BD7Q24299592-D40845BD-1FD1-4DB9-B2A7-281224A9795DQ24310284-C12D2B1D-EEC6-4EFA-B74A-0BDE8AEABA45Q24320262-70CA7E9C-B1F9-4BDC-9058-86E142508306Q24670970-3C2D8F12-9DF2-4223-B374-A0C18DE6B7E6Q27024640-B68AAEF4-CE69-4638-8773-9CED0654607DQ27649143-EAF13D77-5CBE-49B5-8D3C-1AC02F758C69Q27649488-B19AFA94-68D6-479A-8BD8-B8235FE6F326Q27649498-F2FE7C5C-F587-4058-A21C-F9B91F7D1FEAQ27655169-142250BE-2B24-4069-B57F-FA86F60A1A27Q28267084-0AEBAB89-9BB5-4DDA-856B-681C44A1BACDQ28656460-B6612F31-7860-44D2-97C9-5B789FFC5084Q28727262-30D0510D-D788-48CC-93D3-F51AE8741EE0Q30277293-FFDE62E1-2ADE-46B2-8097-C5530B0607CDQ30463364-AA20D2DB-0A9B-48BE-A710-339E3871757AQ30479123-ECFE1F7E-6F49-4A14-860A-06255D59FF67Q30543966-11E01385-372E-4EC1-ACB4-46EF3E005688Q33426121-56A9D83D-F38E-40A3-AF6E-2EC08283A527Q33434632-41EC0E15-13A9-485A-AC62-3F05E556381AQ33517110-D80C2D52-0515-4CAC-BDCC-91DAA4F798F0Q33589801-69832D89-0B76-479A-8D0D-7458A6C291E8Q33718737-D14E39BB-730C-4362-BD1B-F87BB3B308DFQ33729165-E6928C2A-AFD1-4E68-A945-877ABD35220AQ33733718-E75D39A0-ACFC-4FBE-B841-F9D06DE38CD2Q33894042-BB6B8690-741C-4A29-8C96-DFB767BF4E85Q34157345-B6902365-189B-4C63-9B8E-4BEFB9327C51Q34171150-73EE9DE7-F3E0-4E6E-83CB-8130B7FD22F5Q34236471-CCBE9E17-452A-4951-8EB1-2CC7FFF80AE6Q34401723-DC110BB2-E990-4421-99BE-44D0ABF2C99EQ34409204-66CA9588-7A0E-43AF-8E34-062D3B5DB8D2Q34658152-D77FDB28-8D19-448F-B5D3-8F505EAEAB85Q34688769-37FADEC8-8730-4C87-B393-99D64C1BCB74Q34750367-0379A23C-494E-46A0-84E0-89442EE9D906Q34764239-D9BBB366-AA08-4A2B-A84A-43D3E1C545EDQ34770256-0F1D1FDF-6FD4-4DE1-BF64-E351646D2133Q34773994-CB6799A4-95AD-4D39-8381-AFFD1BE664F8Q34787151-40817DD1-4C90-4D69-9162-495449450F76Q35046300-8F38196C-D804-48BE-8DBD-829C93C3CBBFQ35063836-885A0318-9CE2-42D6-9AE2-D1482F2031EAQ35126225-A285F985-C03F-441F-91F5-2E8DCC94F3DA
P2860
Interactions of tumor necrosis factor (TNF) and TNF receptor family members in the mouse and human.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Interactions of tumor necrosis ...... embers in the mouse and human.
@ast
Interactions of tumor necrosis ...... embers in the mouse and human.
@en
Interactions of tumor necrosis factor
@nl
type
label
Interactions of tumor necrosis ...... embers in the mouse and human.
@ast
Interactions of tumor necrosis ...... embers in the mouse and human.
@en
Interactions of tumor necrosis factor
@nl
prefLabel
Interactions of tumor necrosis ...... embers in the mouse and human.
@ast
Interactions of tumor necrosis ...... embers in the mouse and human.
@en
Interactions of tumor necrosis factor
@nl
P2093
P2860
P356
P1476
Interactions of tumor necrosis ...... embers in the mouse and human.
@en
P2093
Aubry Tardivel
Christine Ambrose
Claudia Bossen
Jean-Luc Bodmer
Karine Ingold
Olivier Gaide
Sylvie Hertig
P2860
P304
13964-13971
P356
10.1074/JBC.M601553200
P407
P577
2006-03-17T00:00:00Z